Regeneron Pharmaceuticals... (REGN)
602.46
2.70 (0.45%)
At close: Apr 25, 2025, 3:59 PM
602.64
0.03%
After-hours: Apr 25, 2025, 05:20 PM EDT
Regeneron Pharmaceuticals Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue Revenue | 1.66B | 1.52B | 1.27B | 1.37B | 1.44B | 1.32B | 1.38B | n/a | 1.05B | 1.04B | 1.23B | 86.2M | 1.07B | 954.7M | 754.4M | 1.62B | 1.48B | 1.23B | 1.24B | 1.29B | 1.24B | 1.21B | 1.1B | 2.08B | 1.03B | 996.38M |
| Collaboration Revenue Revenue Growth | +8.93% | +20.30% | -7.53% | -4.75% | +9.24% | -4.46% | n/a | -100.00% | +0.67% | -15.33% | +1329.81% | -91.97% | +12.49% | +26.55% | -53.48% | +9.42% | +20.81% | -0.79% | -3.86% | +3.88% | +2.74% | +9.14% | -47.01% | +103.25% | +2.92% | n/a |
| Product and Service, Other Revenue | 114.2M | 104.5M | 116.9M | 212.5M | 138.3M | 69.3M | 116M | 127.7M | 84.2M | 59.2M | 94M | 3.98B | 99M | 46M | 50M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product and Service, Other Revenue Growth | +9.28% | -10.61% | -44.99% | +53.65% | +99.57% | -40.26% | -9.16% | +51.66% | +42.23% | -37.02% | -97.64% | +3915.35% | +115.22% | -8.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue | 1.95B | 1.92B | 1.76B | 1.85B | 1.79B | 1.77B | 1.67B | 1.7B | 1.8B | 1.75B | 1.64B | n/a | 2.28B | 4.14B | 1.72B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue Growth | +1.45% | +8.93% | -4.89% | +3.68% | +0.79% | +6.24% | -1.84% | -5.67% | +2.68% | +7.07% | n/a | n/a | -44.90% | +139.97% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|
| United States Revenue | 5.89B | 6.89B | 12.12B | 5.57B | 4.83B | 4.11B |
| United States Revenue Growth | -14.63% | -43.11% | +117.64% | +15.17% | +17.73% | n/a |
| Rest Of World Revenue | 324.3M | 73M | n/a | n/a | n/a | n/a |
| Rest Of World Revenue Growth | +344.25% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 792.2M | 714.4M | 758.8M | 689M | 737.7M | 640.5M | 652M | 601.1M | 660.5M | 529.1M | 476.3M | 450M | 559.6M | 445M | 414.7M | 405.6M | 303.5M | 326.9M | 348.3M | 367.3M | 586.8M | 419.9M | 417.3M | 410.8M | 491.3M | 369.23M | 364.88M | 330.77M | 409.91M | 306.77M | 306.91M | 296.85M | 325.94M | 270.05M | 292.04M | 289.68M | 294.95M | 209.99M | 174.59M | 158.99M |
| Selling, General, and Administrative Revenue Growth | +10.89% | -5.85% | +10.13% | -6.60% | +15.18% | -1.76% | +8.47% | -8.99% | +24.83% | +11.09% | +5.84% | -19.59% | +25.75% | +7.31% | +2.24% | +33.64% | -7.16% | -6.14% | -5.17% | -37.41% | +39.75% | +0.62% | +1.58% | -16.39% | +33.06% | +1.19% | +10.31% | -19.31% | +33.62% | -0.05% | +3.39% | -8.93% | +20.70% | -7.53% | +0.82% | -1.79% | +40.46% | +20.28% | +9.81% | n/a |
| Research and Development Revenue | 1.41B | 1.27B | 1.08B | 1.13B | 1.18B | 1.08B | 1.09B | 1.1B | 1.04B | 911.3M | 794.3M | 843.8M | 785.6M | 665.4M | 714.2M | 742.9M | 744.5M | 684.6M | 722M | 583.9M | 683.1M | 663.4M | 1.05B | 641.8M | 601.2M | 556.97M | 529.29M | 498.59M | 527.98M | 529.75M | 509.98M | 507.44M | 479.21M | 543.05M | 559.93M | 470.11M | 461.21M | 425.92M | 390.33M | 343.11M |
| Research and Development Revenue Growth | +11.06% | +17.81% | -4.85% | -3.64% | +9.48% | -0.92% | -1.44% | +5.57% | +14.46% | +14.73% | -5.87% | +7.41% | +18.06% | -6.83% | -3.86% | -0.21% | +8.75% | -5.18% | +23.65% | -14.52% | +2.97% | -36.72% | +63.34% | +6.75% | +7.94% | +5.23% | +6.16% | -5.57% | -0.33% | +3.88% | +0.50% | +5.89% | -11.76% | -3.02% | +19.11% | +1.93% | +8.28% | +9.12% | +13.76% | n/a |